Haleon plc Share Price Nyse

Equities

HLN

US4055521003

Pharmaceuticals

Real-time Estimate Cboe BZX 17:18:36 04/06/2024 BST 5-day change 1st Jan Change
8.375 USD -1.12% Intraday chart for Haleon plc 0.00% +1.94%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 11.45B 14.64B 1,145B Sales 2025 * 11.93B 15.25B 1,193B Capitalization 29.81B 38.11B 2,981B
Net income 2024 * 1.46B 1.87B 146B Net income 2025 * 1.69B 2.16B 169B EV / Sales 2024 * 3.29 x
Net Debt 2024 * 7.82B 10B 782B Net Debt 2025 * 7.08B 9.05B 708B EV / Sales 2025 * 3.09 x
P/E ratio 2024 *
20.3 x
P/E ratio 2025 *
17.7 x
Employees 25,408
Yield 2024 *
1.89%
Yield 2025 *
2.18%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.12%
Current month-0.59%
1 month+1.82%
3 months+0.96%
6 months-0.94%
Current year+1.94%
More quotes
1 week
8.27
Extreme 8.265
8.50
1 month
8.12
Extreme 8.12
8.62
Current year
7.89
Extreme 7.89
8.71
1 year
7.70
Extreme 7.695
8.96
3 years
5.59
Extreme 5.59
9.05
5 years
5.59
Extreme 5.59
9.05
10 years
5.59
Extreme 5.59
9.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21/07/21
Director of Finance/CFO 52 30/11/21
Chief Tech/Sci/R&D Officer - 15/12/21
Members of the board TitleAgeSince
Director/Board Member - 17/07/22
Director/Board Member 64 17/07/22
Director/Board Member 57 17/07/22
More insiders
Date Price Change Volume
04/06/24 8.39 -0.94% 2 362 786
03/06/24 8.47 +0.36% 6,135,515
31/05/24 8.44 +0.72% 3,581,017
30/05/24 8.38 +0.36% 2,483,287
29/05/24 8.35 -0.48% 4,006,022

Delayed Quote Nyse, June 04, 2024 at 05:03 pm

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.264 GBP
Average target price
3.62 GBP
Spread / Average Target
+10.91%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW